Neohesperidin Dihydrochalcone Alleviates Lipopolysaccharide‐Induced Vascular Endothelium Dysfunction by Regulating Antioxidant Capacity
2024

Neohesperidin Dihydrochalcone Reduces Vascular Dysfunction Caused by Lipopolysaccharide

Sample size: 100 publication 10 minutes Evidence: high

Author Information

Author(s): Nong Yuxin, Lu Junquan, Yu Danqing, Wei Xuebiao

Primary Institution: Guangdong Provincial People's Hospital

Hypothesis

Does neohesperidin dihydrochalcone (NHDC) alleviate lipopolysaccharide (LPS)-induced vascular dysfunction?

Conclusion

Pretreatment with NHDC may protect against LPS-induced vascular dysfunction by reducing oxidative stress and inflammatory signaling.

Supporting Evidence

  • NHDC reduced protein extravasation in response to LPS intervention.
  • NHDC improved survival rates in mice after LPS injection.
  • NHDC decreased the levels of inflammatory cytokines IL-1β, IL-6, and TNF-α.
  • NHDC enhanced antioxidant capacity by increasing CAT, SOD, and GSH levels.
  • NHDC mitigated LPS-induced apoptosis in endothelial cells.

Takeaway

This study shows that a sweetener called NHDC can help protect blood vessels from damage caused by bacteria.

Methodology

The study used in vivo and in vitro experiments to assess the effects of NHDC on vascular leakage and endothelial cell function.

Limitations

The study used a mouse model which may not fully replicate human sepsis conditions.

Participant Demographics

C57BL/6 male mice, 8 weeks old, weighing 20–25 g.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1002/iid3.70107

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication